Restricted MHC-peptide repertoire predisposes to autoimmunity

Journal of Experimental Medicine

Volumn 202, Issue 1, 2005, Pages 73-84

  Logunova, Nadezda N ^a   Viret, Christophe ^b,d   Pobezinsky, Leonid A ^a   Miller, Sara A ^a   Kazansky, Dmitri B ^c   Sundberg, John P ^a   Chervonsky, Alexander V ^a  

^a JACKSON LABORATORY   (United States)

^b YALE UNIVERSITY   (United States)

^c Cancer Research Center   (Russian Federation)

^d CEA GRENOBLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE;

ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CLINICAL FEATURE; CONTROLLED STUDY; DERMATITIS; DISEASE PREDISPOSITION; FEMALE; GENETIC LINKAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REDUCTION; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DERMATITIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL;

EID: 22344442179     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20050198     Document Type: Article

References (49)

1. Nepon, G.T. 1998. Major histocompatibility complex-directed susceptibility to rheumatoid arthritis. Adv. Immunol. 68:315-332.
2. Nepon, G.T., and W.W. Kwok. 1998. Molecular basis for HLA-DQ associations with IDDM. Diabetes. 47:1177-1184.
3. Dessen, A., C.M. Lawrence, S. Cupo, D.M. Zaller, and D.C. Wiley. 1997. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity. 7:473-481.
4. Corper, A.L., T. Stratmann, V. Apostolopoulos, C.A. Scott, K.C. Garcia, A.S. Kang, I.A. Wilson, and L. Teyton. 2000. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science. 288:505-511.
5. Latek, R.R., A. Suri, S.J. Petzold, C.A. Nelson, O. Kanagawa, E.R. Unanue, and D.H. Fremont. 2000. Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. Immunity. 12:711-720.
6. g7 molecules from non-obese diabetic mice are poor peptide binders. J. Immunol. 156:450-458.
7. Woulfe, S.L., C.P. Bono, D.A. Zacheis, T.A. Kirschmann, C.S. Baudino, R.W. Karr, and B.D. Schwartz. 1995. Negatively charged residues interacting with the p4 pocket confer binding specificity to DRB1*0401. Arthritis Rheum. 38:1744-1753.
8. Ignatowicz, L., J. Kappler, and P. Marrack. 1996. The repertoire of T cells shaped by a single MHC/peptide ligand. Cell. 84:521-529.
9. Shachar, I., and R.A. Flavell. 1996. Requirement for invariant chain in B cell maturation and function. Science. 274:106-108.
10. Benlagha, K., S.H. Park, R. Guinamard, C. Forestier, L. Karlsson, C.H. Chang, and A. Bendelac. 2004. Mechanisms governing B cell developmental defects in invariant chain-deficient mice. J. Immunol. 172:2076-2083.
11. Ignatowicz, L., G. Winslow, J. Bill, J. Kappler, and P. Marrack. 1995. Cell surface expression of class II MHC proteins bound by a single peptide. J. Immunol. 154:3852-3862.
12. Chervonsky, A.V., R.M. Medzhitov, L.K. Denzin, A.K. Barlow, A.Y. Rudensky, and C.A. Janeway Jr. 1998. Subtle conformational changes induced in major histocompatibility complex class II molecules by binding peptides. Proc. Natl. Acad. Sci. USA. 95:10094-10099.
13. Gaszewska-Mastalarz, A., P. Muranski, B. Chmielowski, P. Kraj, and L. Ignatowicz. 2000. Altered selection of CD4+ T cells by class II MHC bound with dominant and low abundance self-peptides. J. Immunol. 165:6099-6106.
14. Wright, A.L., and A.G. Messenger. 1990. Scarring alopecia in psoriasis. Acta Derm. Venereol. 70:156-159.
15. Stanimirovic, A., M. Skerlev, T. Stipic, T. Beck, A. Basta-Juzbasic, and D. Ivankovic. 1998. Has psoriasis its own characteristic trichogram? J. Dermatol. Sci. 17:156-159.
16. Madsen, L., N. Labrecque, J. Engberg, A. Dierich, A. Svejgaard, C. Benoist, D. Mathis, and L. Fugger. 1999. Mice lacking all conventional MHC class II genes. Proc. Natl. Acad. Sci. USA. 96:10338-10343.
17. He, X., C.A. Janeway Jr., M. Levine, E. Robinson, P. Preston-Hurlburt, C. Viret, and K. Bottomly. 2002. Dual receptor T cells extend the immune repertoire for foreign antigens. Nat. Immunol. 3:127-134.
18. Padovan, E., G. Casorati, P. Dellabona, C. Giachino, and A. Lanzavecchia. 1995. Dual receptor T-cells. Implications for alloreactivity and autoimmunity. Ann. N. Y. Acad. Sci. 756:66-70.
19. Riberdy, J.M., E. Mostaghel, and C. Doyle. 1998. Disruption of the CD4-major histocompatibility complex class II interaction blocks the development of CD4(+) T cells in vivo. Proc. Natl. Acad. Sci. USA. 95:4493-4498.
20. Sanderson, S., and N. Shastri. 1994. LacZ inducible, antigen/MHCspecific T cell hybrids. Int. Immunol. 6:369-376.
21. Pfizenmaier, K., G. Trinchieri, D. Solter, and B.B. Knowles. 1978. Mapping of H-2 genes associated with T cell-mediated cytotoxic responses to SV40-tumour-associated specific antigens. Nature. 274:691-693.
22. Liu, G.Y., P.J. Fairchild, R.M. Smith, J.R. Prowle, D. Kioussis, and D.C. Wraith. 1995. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity. 3:407-415.
23. Fairchild, P.J., R. Wildgoose, E. Atherton, S. Webb, and D.C. Wraith. 1993. An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. Int. Immunol. 5:1151-1158.
24. Ridgway, W.M., M. Fasso, C.G. Fathman. 1999. A new look at MHC and autoimmune disease. Science. 284:749-751.
25. Ridgway, W.M., and C.G. Fathman. 1999. MHC structure and autoimmune T cell repertoire development. Curr. Opin. Immunol. 11:638-642.
26. Kisielow, P., H. Bluthmann, U.D. Staerz, M. Steinmetz, and H. von Boehmer. 1988. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature. 333:742-746.
27. Huseby, E.S., F. Crawford, J. White, J. Kappler, and P. Marrack. 2003. Negative selection imparts peptide specificity to the mature T cell repertoire. Proc. Natl. Acad. Sci. USA. 100:11565-11570.
28. Lund, T., L. O'Reilly, P. Hutchings, O. Kanagawa, E. Simpson, R. Gravely, P. Chandler, J. Dyson, J.K. Picard, A. Edwards, et al. 1990. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain. Nature. 345:727-729.
29. Slattery, R.M., L. Kjer-Nielsen, J. Allison, B. Charlton, T.E. Mandel, and J.F. Miller. 1990. Prevention of diabetes in non-obese diabetic I-Ak transgenic mice. Nature. 345:724-726.
30. Bohme, J., B. Schuhbaur, O. Kanagawa, C. Benoist, and D. Mathis. 1990. MHC-linked protection from diabetes dissociated from clonal deletion of T cells. Science. 249:293-295.
31. Todd, J.A., and L.S. Wicker. 2001. Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. Immunity. 15:387-395.
32. Siebold, C., B.E. Hansen, J.R. Wyer, K. Harlos, R.E. Esnouf, A. Svejgaard, J.I. Bell, J.L. Strominger, E.Y. Jones, and L. Fugger. 2004. Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy. Proc. Natl. Acad. Sci. USA. 101:1999-2004.
33. Oono, T., Y. Fukui, S. Masuko, O. Hashimoto, T. Ueno, T. Sanui, A. Inayoshi, M. Noda, M. Sata, and T. Sasazuki. 2001. Organ-specific autoimmunity in mice whose T cell repertoire is shaped by a single antigenic peptide. J. Clin. Invest. 108:1589-1596.
34. Arsov, I., and S. Vukmanovic. 1999. Dual MHC class I and class II restriction of a single T cell receptor: distinct modes of tolerance induction by two classes of autoantigens. J. Immunol. 162:2008-2015.
35. Tyznik, A.J., J.C. Sun, and M.J. Bevan. 2004. The CD8 population in CD4-deficient mice is heavily contaminated with MHC class II-restricted T cells. J. Exp. Med. 199:559-565.
36. Lee, D.S., C. Ahn, B. Ernst, J. Sprent, and C.D. Surh. 1999. Thymic selection by a single MHC/peptide ligand: autoreactive T cells are low-affinity cells. Immunity. 10:83-92.
37. Hernandez-Hoyos, G., S.J. Sohn, E.V. Rothenberg, and J. Alberola-Ila. 2000. Lck activity controls CD4/CD8 T cell lineage commitment. Immunity. 12:313-322.
38. Doyle, C., and J.L. Strominger. 1987. Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature. 330:256-259.
39. Salter, R.D., R.J. Benjamin, P.K. Wesley, S.E. Buxton, T.P. Garrett, C. Clayberger, A.M. Krensky, A.M. Norment, D.R. Littman, and P. Parham. 1990. A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2. Nature. 345:41-46.
40. Serreze, D.V., T.M. Holl, M.P. Marron, R.T. Graser, E.A. Johnson, C. Choisy-Rossi, R.M. Slattery, S.M. Lieberman, and T.P. DiLorenzo. 2004. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice. J. Immunol. 172:871-879.
41. Vugmeyster, Y., R. Glas, B. Perarnau, F.A. Lemonnier, H. Eisen, and H. Ploegh. 1998. Major histocompatibility complex (MHC) class I KbDb -/- deficient mice possess functional CD8+ T cells and natural killer cells. Proc. Natl. Acad. Sci. USA. 95:12492-12497.
42. Mombaerts, P., A.R. Clarke, M.A. Rudnicki, J. Iacomini, S. Itohara, J.J. Lafaille, L. Wang, Y. Ichikawa, R. Jaenisch, M.L. Hooper, et al. 1992. Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature. 360:225-231.
43. Casanova, J.L., P. Romero, C. Widmann, P. Kourilsky, and J.L. Maryanski. 1991. T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide: implications for T cell allelic exclusion and antigen-specific repertoire. J. Exp. Med. 174:1371-1383.
44. Kouskoff, V., K. Signorelli, C. Benoist, and D. Mathis. 1995. Cassette vectors directing expression of T cell receptor genes in transgenic mice. J. Immunol. Methods. 180:273-280.
45. Cobbold, S.P., A. Jayasuriya, A. Nash, T.D. Prospero, and H. Waldmann. 1984. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature. 312:548-551.
46. Janeway, C.A., Jr., P.J. Conrad, E.A. Lerner, J. Babich, P. Wettstein, and D.B. Murphy. 1984. Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: possible role of T cellbound Ia antigens as targets of immunoregulatory T cells. J. Immunol. 132:662-667.
47. Ledbetter, J.A., and L.A. Herzenberg. 1979. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47:63-90.
48. Dialynas, D.P., D.B. Wilde, P. Marrack, A. Pierres, K.A. Wall, W. Havran, G. Otten, M.R. Loken, M. Pierres, J. Kappler, and F.W. Fitch. 1983. Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity. Immunol. Rev. 74:29-56.
49. Tokura, Y., J. Yagi, M. O'Malley, J.M. Lewis, M. Takigawa, R.L. Edelson, and R.E. Tigelaar. 1994. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines. J. Invest. Dermatol. 102:31-38.